Immunotherapy for Head and Neck Squamous Cell Carcinoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference65 articles.
1. Decision making in the management of recurrent head and neck cancer;Ho;Head Neck,2014
2. Optimal treatment for recurrent/metastatic head and neck cancer;Vermorken;Ann Oncol,2010
3. Head and neck cancer;Argiris;Lancet,2008
4. Classification of current anticancer immunotherapies;Galluzzi;Oncotarget,2014
5. Uber den jetzigen Stand der Karzinomforschung;Ehrlich;Ned Tijdschr Geneeskd,1909
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy for head and neck cancer: Fundamentals and therapeutic development;Auris Nasus Larynx;2024-08
2. Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis;Frontiers in Immunology;2024-01-17
3. Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer;Therapeutic Advances in Medical Oncology;2024-01
4. Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC);Expert Review of Gastroenterology & Hepatology;2023-09-13
5. Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature;Therapeutic Advances in Medical Oncology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3